NASDAQ Equity Snapshot
PBM Weekly Equity Report
Psyence Biomedical Ltd. Common Shares
What the company does
Psyence Biomedical Ltd. (PBM) is a cutting-edge biotechnology firm focused on harnessing the therapeutic potential of psychedelic compounds to transform mental health and wellness treatments. Through its vertically integrated model, the company excels in the cultivation, formulation, and clinical research of psilocybin and other psychedelics, aiming to develop novel therapies that meet the pressing needs of patients. With a robust intellectual property portfolio and a promising clinical pipeline, Psyence is strategically positioned to leverage the increasing acceptance of psychedelics in the healthcare landscape, addressing urgent mental health challenges with innovative and effective solutions.
What the weekly tape is saying
PBM closed the latest completed week at 3.33 USD. The 4-week return is -32.2% and the 12-week return is 38.8%. Trend Signal is inactive, Market Dynamics is 1.69. Setup signature: Risk-first tape with a 15/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 16.50 USD
- Vs Trend Line
- -79.8%
- Fair Value
- 4,835 USD
- Vs Fair Value
- -99.9%
- 52W High
- 468.4 USD
- 52W Low
- 1.92 USD
- Drawdown
- -99.3%
- Range Position
- 0.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 833 of 1038
- Sector Percentile
- 19.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.69
- 4W MD Change
- -9.0%
- Relative Strength
- -96.48
- 4W RS Change
- -0.9%
- Expectation
- Negative
- Probability
- 34.38%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 321.3K
- 13W Average
- 11.5M
- 52W Average
- 7.5M
- Vs 13W
- 0.0x
- Vs 52W
- 0.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 51.4%
- 52W Volatility
- 39.3%
- Upside Weeks
- 19
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 28.1% / -16.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 9.5M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3.33 USD | -5.1% | 16.50 USD | 4,835 USD | 1.69 | -96.48 | 321.3K | Off |
| 5 Jun 2026 | 3.51 USD | -15.4% | 19.92 USD | 4,875 USD | 1.77 | -96.38 | 749.0K | Off |
| 29 May 2026 | 4.15 USD | 1.2% | 22.81 USD | 4,915 USD | 1.79 | -96.13 | 249.8K | Off |
| 22 May 2026 | 4.10 USD | -16.5% | 26.78 USD | 4,955 USD | 1.80 | -96.25 | 471.5K | Off |
| 15 May 2026 | 4.91 USD | -12.2% | 30.99 USD | 4,996 USD | 1.86 | -95.63 | 510.5K | Off |
| 8 May 2026 | 5.59 USD | -10.6% | 35.41 USD | 5,038 USD | 1.85 | -95.27 | 703.9K | Off |
| 1 May 2026 | 6.25 USD | -21.0% | 39.93 USD | 5,081 USD | 1.47 | -94.60 | 2.8M | Off |
| 24 Apr 2026 | 7.91 USD | 4.1% | 43.91 USD | 5,124 USD | 1.03 | -93.26 | 49.8M | Off |
| 17 Apr 2026 | 7.60 USD | 184.6% | 47.70 USD | 5,169 USD | 0.49 | -93.62 | 93.3M | Off |
| 10 Apr 2026 | 2.67 USD | 8.1% | 53.64 USD | 5,213 USD | -0.00 | -97.69 | 129.9K | Off |
| 2 Apr 2026 | 2.47 USD | -3.5% | 58.29 USD | 5,259 USD | -0.18 | -97.84 | 75.8K | Off |
| 27 Mar 2026 | 2.56 USD | 6.7% | 61.71 USD | 5,306 USD | -0.30 | -97.75 | 73.5K | Off |
| 20 Mar 2026 | 2.40 USD | -2.4% | 65.29 USD | 5,353 USD | -0.38 | -98.03 | 71.8K | Off |
| 13 Mar 2026 | 2.46 USD | -2.0% | 69.43 USD | 5,401 USD | -0.52 | -98.09 | 75.2K | Off |